There was a time when the mid-cap segment was one of the most vulnerable in the market. The reason: Lack of participation by domestic insti...

As an investor, while it is probably time to be bullish, remember two things. One: Valuations are still not cheap. And two: Because it is o...

In the last three trading sessions, the one thing clearly favouring the bulls was market breadth, especially in the mid-cap segment. A part...

In the last three weeks, the correction in the market has been led by mid-cap stocks. There is one common thread which runs through the sto...

The FII selling that caused sharp cuts in the Indian markets was based on the assumption that China would see an economic recovery. This sp...

Huawei Technologies Co., a Chinese telecommunications giant blacklisted by the US, is secretly funding cutting-edge research at American un...

Moderna Inc has begun dosing patients in a mid-to-late stage study of its COVID-19 vaccine, mRNA-1273, in children aged six months to less ...

With efficacy of just over 50% - barely above Brazil's threshold for regulatory approval - the Chinese shot was not the government's first ...

COVAXX, a unit of privately-owned United Biomedical Inc, plans to pursue mid- and late-stage trials for the vaccine candidate from early 20...

The first U.S. vaccine shipments departed Pfizer's facility in Kalamazoo, Michigan this week, while tens of thousands of people in Britain ...

The researchers said they could not be sure who was behind the campaign, which began in September, or if it was successful. But the precisi...

It will seek emergency use authorization from the U.S. Food and Drug Administration and conditional approval from the European Union on Mon...

A wide range of symptoms and severity makes the evaluation of Covid-19 vaccines tricky. The U.S. Food and Drug Administration has said that...

More than 90 vaccines are currently being developed globally, with eight in the clinical trial phase. But experts say the process could tak...

For the winners, the potential market is huge. Diabetes device sales totaled $14 billion in the US last year.

Many US corporations are wedded to the concept of supplier diversity and are keen on diversifying their supply chains by extending opportun...

US exports to Iran grew more than tenfold during Bush's years in office even as he accused Iran of nuclear ambitions and helping terrorists.